NCT02176525
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
Not specified
Clinical trial condition
Hepatitis C
Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.
449 public trials
3 recruiting studies
Hepatitis C trial results
NCT01066793
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Aalst, Belgium
- Antwerp, Belgium
- Antwerp, Belgium
- Bruges, Belgium
NCT00227435
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
- Locations
-
- Pasadena, California, United States
- Boston, Massachusetts, United States
- Worcester, Massachusetts, United States
- Fairfax, Virginia, United States
NCT00905632
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- 1241.7.3307A CHU de Grenoble Grenoble Cédex 9, France
- 1241.7.3303A Hôpital Claude Huriez Lille, France
- 1241.7.3302A Hopital de l'Hotel Dieu Lyon, France
- 1241.7.3301A Hôpital Saint Eloi Montpellier, France
NCT01732796
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- 1241.20.00026 Boehringer Ingelheim Investigational Site Dothan, Alabama, United States
- 1241.20.00033 Boehringer Ingelheim Investigational Site Chula Vista, California, United States
- 1241.20.00006 Boehringer Ingelheim Investigational Site La Mesa, California, United States
- 1241.20.00003 Boehringer Ingelheim Investigational Site Oceanside, California, United States
NCT00077649
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- La Jolla, California, United States
- Long Beach, California, United States
- San Diego, California, United States
- San Diego, California, United States
NCT01528735
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- 1241.25.002 Boehringer Ingelheim Investigational Site Kofu, Yamanashi, Japan
- 1241.25.005 Boehringer Ingelheim Investigational Site Kurashiki, Okayama, Japan
- 1241.25.003 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan
- 1241.25.004 Boehringer Ingelheim Investigational Site Nishinomiya, Hyogo, Japan
NCT00412334
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Angers, France
- Bobigny, France
- Châteauroux, France
- Créteil, France
NCT02557646
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Ajka, Hungary
- Balassagyarmat, Hungary
- Békéscsaba, Hungary
- Budapest, Hungary
Completed
The SIM-SOF Trial for Hepatitis C
NCT02168361
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
- Locations
-
- Center for Hepatitis C Atlanta, Georgia, United States